Regado Biosciences Inc., in the Basking Ridge section of Bernards, announced today the appointment of Michael A. Metzger as president and chief operating officer.
According to the announcement, Metzger will oversee corporate and business development strategy and planning, as well as other key business functions of the company. He was previously executive vice president and chief operating officer at Mersana Therapeutics, where he drove the establishment and management of business alliances and was one of the architects of the strategic direction, financing and growth of the business, which led to Mersana being named a Fierce15 Biotech Company for 2012.
Prior to joining Mersana in 2011, Mr. Metzger held senior positions within business development and led mergers and acquisitions at Forest Laboratories Inc. Prior to Forest, Metzger served as vice pesident of Corporate Development at Onconova Therapeutics Inc., a pivotal-stage biopharmaceutical company focused in oncology, and Managing Director at MESA Partners, a venture capital firm, Regado said in a statement.
The company's initial public offering generated $43 million in gross proceeds in August.